Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 4
2009 2
2010 1
2011 4
2012 4
2013 2
2014 2
2015 1
2016 1
2018 4
2019 3
2020 3
2021 4
2022 9
2023 2
2024 6
2025 3
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.
Rojas CAO, Pereira-Martins DA, Thomé CH, Ferreira GA, Bianco TM, Weinhäuser I, Gouvêa AS, Scheucher PS, Silva CLA, Huls G, Bermudez A, Garcia F, Pitteri S, Faça VM, Ammatuna E, Schuringa JJ, Glória AB, Pagnano KBB, Nunes EC, Traina F, De Figueiredo-Pontes LL, Rego EM. Rojas CAO, et al. Haematologica. 2026 May 28. doi: 10.3324/haematol.2025.288595. Online ahead of print. Haematologica. 2026. PMID: 42206432 Free article.
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-trans retinoic acid.
Silva WF, Kim HT, Undurraga MS, Navarro-Cabrera JR, Salinas V, Muxi P, Melo RAM, Gloria ABF, Pagnano KBB, Nunes EC, Bittencourt RI, Rojas N, Truyenque SMQ, Ayala-Lugo AI, Oliver AC, Figueiredo-Pontes LL, Traina F, Moreira F, Fagundes EM, Duarte BKL, Mora-Alferez AP, Ortiz P, Untama JL, Tallman MS, Ribeiro RC, Ganser A, Dillon RJ, Valk PJM, Sanz MA, Löwenberg B, Berliner N, Rego EM. Silva WF, et al. Haematologica. 2025 Mar 1;110(3):795-798. doi: 10.3324/haematol.2024.286338. Haematologica. 2025. PMID: 39479861 Free PMC article. No abstract available.
Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia.
Salustiano-Bandeira ML, Moreira-Aguiar A, Pereira-Martins DA, Coelho-Silva JL, Weinhäuser I, França-Neto PL, Lima AS, Lima AS, Baccarin AR, Silva FB, de Melo MA, Niemann FS, Nardinelli L, Ortiz Rojas CA, Duarte BK, Araujo AS, Azevedo EA, Morais CN, Figueiredo-Pontes LL, Schuringa JJ, Huls G, Bendit I, Rego EM, Olalla Saad ST, Traina F, Bezerra MA, Lucena-Araujo AR. Salustiano-Bandeira ML, et al. Blood Cancer J. 2024 Jun 24;14(1):102. doi: 10.1038/s41408-024-01086-8. Blood Cancer J. 2024. PMID: 38914584 Free PMC article. No abstract available.
Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy.
de Figueiredo-Pontes LL, Catto LFB, Chauffaille MLLF, Pagnano KBB, Madeira MIA, Nunes EC, Hamerschlak N, de Andrade Silva MC, Carneiro TX, Bortolheiro TC, de Freitas TT, Bittencourt RI, Maranhão Fagundes E, Magalhães Rego E. de Figueiredo-Pontes LL, et al. Hematol Transfus Cell Ther. 2024 Oct-Dec;46(4):553-569. doi: 10.1016/j.htct.2024.05.002. Epub 2024 May 18. Hematol Transfus Cell Ther. 2024. PMID: 38890097 Free PMC article.
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.
Koury LCA, Kim HT, Undurraga MS, Navarro-Cabrera JR, Salinas V, Muxi P, Melo RAM, Glória AB, Pagnano K, Nunes EC, Bittencourt RI, Rojas N, Quintana S, Ayala-Lugo A, Oliver AC, Figueiredo-Pontes L, Traina F, Moreira F, Fagundes EM, Duarte BKL, Mora-Alferez AP, Ortiz P, Untama J, Tallman M, Ribeiro R, Ganser A, Dillon R, Valk PJM, Sanz M, Löwenberg B, Berliner N, Rego EM. Koury LCA, et al. Blood. 2024 Sep 19;144(12):1257-1270. doi: 10.1182/blood.2024023890. Blood. 2024. PMID: 38805638 Free article.
Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study.
Murbach B, Duarte G, Palma LC, Miranda E, Duffles G, Furlin GP, Toni I, De Souza C, Binelli L, Bassan VL, de Castro FA, de Figueiredo-Pontes LL, Pagnano KBB. Murbach B, et al. Front Oncol. 2024 May 8;14:1393191. doi: 10.3389/fonc.2024.1393191. eCollection 2024. Front Oncol. 2024. PMID: 38779092 Free PMC article.
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia.
de Castro FA, Mehdipour P, Chakravarthy A, Ettayebi I, Loo Yau H, Medina TS, Marhon SA, de Almeida FC, Bianco TM, Arruda AGF, Devlin R, de Figueiredo-Pontes LL, Chahud F, da Costa Cacemiro M, Minden MD, Gupta V, De Carvalho DD. de Castro FA, et al. Br J Haematol. 2024 Jan;204(1):206-220. doi: 10.1111/bjh.19107. Epub 2023 Sep 19. Br J Haematol. 2024. PMID: 37726227
48 results